GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

ELAN · Dec 31, 2024

Elanco Animal Health Inc. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001739104-25-000014General Corporate
Debt relative to revenue5thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.debt_to_revenue

97.34% · OPTIONAL · VALID

Capex intensity70thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.capex_revenue_ratio

3.31% · OPTIONAL · VALID

Operating cash generation70thOwn-history percentile · N=20
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

12.19% · OPTIONAL · VALID

Revenue growth55thOwn-history percentile · N=20
Evidence method

Yoy · gp.fundamentals.revenue

0.50% · CORE · VALID

Inventory pressure15thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

35.46% · OPTIONAL · VALID

Gross margin45thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.gross_margin

54.88% · CORE · VALID

R&D intensity60thOwn-history percentile · N=20
Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

7.75% · OPTIONAL · VALID

SBC intensity40thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

1.24% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History28 statesSelf-history eligible
Sep 30, 20218/8 normalizedLevel 3Dec 31, 20218/8 normalizedLevel 3Mar 31, 20228/8 normalizedLevel 3Jun 30, 20228/8 normalizedLevel 3Sep 30, 20228/8 normalizedLevel 3Dec 31, 20228/8 normalizedLevel 3Mar 31, 20238/8 normalizedLevel 3Jun 30, 20237/7 normalizedLevel 3Sep 30, 20237/7 normalizedLevel 3Dec 31, 20238/8 normalizedLevel 3Mar 31, 20248/8 normalizedLevel 3Jun 30, 20248/8 normalizedLevel 3Sep 30, 20248/8 normalizedLevel 3Dec 31, 20248/8 normalizedLevel 3Mar 31, 20258/8 normalizedLevel 3Jun 30, 20258/8 normalizedLevel 3Sep 30, 20258/8 normalizedLevel 3Dec 31, 20258/8 normalizedLevel 3Mar 31, 20268/8 normalizedLevel 3Jun 30, 20268/8 normalizedLevel 4
Period transition

What moved in the state?

Balance Sheet Leverage Decreased
Previous
423.01%
Current
97.34%
Delta
-325.67%
Capex Intensity Decreased
Previous
4.08%
Current
3.31%
Delta
-0.77%
Cash Generation Decreased
Previous
15.73%
Current
12.19%
Delta
-3.54%
Growth Increased
Previous
-3.56%
Current
0.50%
Delta
4.06%
Inventory Pressure Decreased
Previous
158.45%
Current
35.46%
Delta
-122.99%
Margin Increased
Previous
52.23%
Current
54.88%
Delta
2.64%
R And D Intensity Decreased
Previous
8.45%
Current
7.75%
Delta
-0.70%
Sbc Intensity Decreased
Previous
1.46%
Current
1.24%
Delta
-0.22%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Transitioned To · ELAN Fundamental State →Has State · Elanco Animal Health Inc →Transitioned To · ELAN Fundamental State →Transitioned To · ELAN BALANCE_SHEET_LEVERAGE_DECREASED →Transitioned To · ELAN CAPEX_INTENSITY_DECREASED →Transitioned To · ELAN CASH_GENERATION_DECREASED →Transitioned To · ELAN GROWTH_INCREASED →Transitioned To · ELAN INVENTORY_PRESSURE_DECREASED →Transitioned To · ELAN MARGIN_INCREASED →Transitioned To · ELAN R_AND_D_INTENSITY_DECREASED →Transitioned To · ELAN SBC_INTENSITY_DECREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.